Biological response of B lymphoma cell lines to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement mediated lysis.

被引：0
|
作者：
Golay, J
Zaffaroni, L
Vaccari, T
Borleri, GM
Tedesco, F
Dastoli, G
Barbui, T
Rambaldi, A
Introna, M
机构：
[1] Ist Ric Farmacol Mario Negri, Milan, Italy
[2] Osped Riuniti Bergamo, Div Hematol, I-24100 Bergamo, Italy
[3] Roche Italia, Milan, Italy
[4] Univ Trieste, Trieste, Italy
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
401
引用
收藏
页码：92A / 92A
页数：1
相关论文
共 50 条
  • [31] Prenyltransferases Regulate CD20 Protein Levels and Influence Anti-CD20 Monoclonal Antibody-mediated Activation of Complement-dependent Cytotoxicity
    Winiarska, Magdalena
    Nowis, Dominika
    Bil, Jacek
    Glodkowska-Mrowka, Eliza
    Muchowicz, Angelika
    Wanczyk, Malgorzata
    Bojarczuk, Kamil
    Dwojak, Michal
    Firczuk, Malgorzata
    Wilczek, Ewa
    Wachowska, Malgorzata
    Roszczenko, Katarzyna
    Miaczynska, Marta
    Chlebowska, Justyna
    Basak, Grzegorz Wladyslaw
    Golab, Jakub
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (38) : 31983 - 31993
  • [32] THE EXPRESSION OF THE COMPLEMENT REGULATORS CD46, CD55, AND CD59 BY HUMAN SPERM DOES NOT PROTECT THEM FROM ANTISPERM ANTIBODY-MEDIATED AND COMPLEMENT-MEDIATED IMMUNE INJURY
    DCRUZ, OJ
    HAAS, GG
    [J]. FERTILITY AND STERILITY, 1993, 59 (04) : 876 - 884
  • [33] The expression of membranous complement inhibitors CD46, CD55 and CD59 in the primary and metastatic colon cancer cell lines derived from the same patient
    Wilczek, Ewa
    Wasiutynski, Aleksander
    Sladowski, Dariusz
    Wilczynski, Grzegorz M.
    Gornicka, Barbara
    [J]. CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2013, 38 (04) : 549 - 555
  • [34] ANTIBODY-DEPENDENT COMPLEMENT-MEDIATED CYTOTOXICITY IN SERA FROM PATIENTS WITH HIV-1 INFECTION IS CONTROLLED BY CD55 AND CD59
    SCHMITZ, J
    ZIMMER, JP
    KLUXEN, B
    ARIES, S
    BOGEL, M
    GIGLI, I
    SCHMITZ, H
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03): : 1520 - 1526
  • [35] Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells
    Brasoveanu, LI
    Altomonte, M
    Fonsatti, E
    Colizzi, F
    Coral, S
    Nicotra, MR
    Cattarossi, I
    Cattelan, A
    Natali, PG
    Maio, M
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 33 - 42
  • [36] Monoclonal Antibody Therapy for B-Cell Lymphoma: Clinical Trials of an Anti-CD20 Monoclonal Antibody for B-Cell Lymphoma in Japan
    Kensei Tobinai
    [J]. International Journal of Hematology, 2002, 76 : 411 - 419
  • [37] Monoclonal antibody therapy for B-Cell lymphoma: Clinical trials of an anti-CD20 monoclonal antibody for B-cell lymphoma in Japan
    Tobinai, K
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (05) : 411 - 419
  • [38] Tetravalent anti-CD20/CD3 bispecific antibody for the treatment of B cell lymphoma
    Lu, Chia-Yen
    Chen, Gregory J.
    Tai, Pei-Han
    Yang, Yu-Chen
    Hsu, Yu-Shen
    Chang, Mingi
    Hsu, Chuan-Lung
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 473 (04) : 808 - 813
  • [39] IN VITRO ANALYSIS OF NOVEL ANTI-CD20 ANTIBODY GA101 AND RITUXIMAB IN MANTLE CELL LYMPHOMA
    Heinrich, D.
    Decheva, K.
    Weinkauf, M.
    Hutter, G.
    Zimmermann, Y.
    Weiglein, T.
    Hiddemann, W.
    Dreyling, M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 70 - 70
  • [40] Successful treatment of refractory low grade duodenal lymphoma with rituximab, an anti-cd20 monoclonal antibody
    Ahmed, S
    Singh, A
    Krauss, J
    Wentz, T
    Gunaratnam, NT
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : 408 - 410
12345